BRINZOLAMIDE/BRIMONIDINE ZENTIVA 10 mg/2 mg per ml, eye drop suspension bottle, 5 ml
Active ingredients: Brimonidine, Brinzolamide, Brimonidine tartrate
Commercialized according to BDPMDispensing in France: Prescription only
Eye drop suspensionbottle, 5 mlophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BRINZOLAMIDE/BRIMONIDINE ZENTIVA 10 mg/2 mg par mL, collyre en suspension
- Pharmaceutical form
- collyre en suspension
- Route of administration
- ophtalmique
- Presentation description
- 1 flacon de 5 mL muni d’un embout compte-gouttes polyéthylène basse densité (PEBD) avec fermeture à témoin d'effraction
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 11 Jul 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69889737CIP73028268CIP133400930282687Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BRIMONIDINEcollyre | 1,3 mg · 1 mL de suspension | FT |
| BRINZOLAMIDEcollyre | 10 mg · 1 mL de suspension | SA |
| TARTRATE DE BRIMONIDINEcollyre | 2 mg · 1 mL de suspension | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.